Johnston Richard B
Department of Pediatrics, University of Colorado School of Medicine and National Jewish Medical and Research Center, Denver, CO 80262, USA.
Pediatr Res. 2008 Jan;63(1):2-8. doi: 10.1203/PDR.0b013e31815b8ec5.
To reduce neural tube defects (NTDs), the U.S. Food and Drug Administration (FDA) mandated that by January 1998 all enriched grain products should contain 140 microg of folic acid (FA)/100 g of flour. Groups concerned with optimal prevention of NTDs had argued that the level should be 350 microg/100 g. However, when it appeared that the debate might delay implementation of any fortification, these groups petitioned the FDA to implement fortification at the originally proposed level of 140 microg/100 g, anticipating that the FDA might consider increasing the level at a later time. Mandated FA fortification (FAF) has now been in place in the United States for 9 y. The impact of this important public health intervention on NTD rates, the possible benefit to other disease conditions, and potential harms have been evaluated. As background for a possible request that the FDA consider increasing FAF, evidence bearing on the question of whether an increase can further reduce NTD births without causing harm is reviewed here. The published data indicate that it is appropriate that the FDA conduct or commission a balanced analysis of the evidence by scientists who will act on that evidence to decide this important question.
为了减少神经管缺陷(NTDs),美国食品药品监督管理局(FDA)规定,到1998年1月,所有强化谷物产品每100克面粉应含有140微克叶酸(FA)。关注NTDs最佳预防的团体认为该水平应为每100克350微克。然而,当这场争论似乎可能会推迟任何强化措施的实施时,这些团体请求FDA按照最初提议的每100克140微克的水平实施强化,预计FDA可能会在以后考虑提高该水平。强制叶酸强化(FAF)在美国现已实施9年。已对这一重要公共卫生干预措施对NTDs发生率的影响、对其他疾病状况可能的益处以及潜在危害进行了评估。作为FDA可能考虑提高FAF请求的背景,本文回顾了有关提高FAF是否能在不造成伤害的情况下进一步减少NTD出生这一问题的相关证据。已发表的数据表明,FDA由将依据该证据采取行动的科学家对证据进行平衡分析来决定这个重要问题是恰当的。